Abstract
Su et al. develop two potent small-molecule inhibitors against an RNA N6-methyladenosine demethylase called FTO. FTO inhibition shows anti-tumor effects in several types of cancers in mouse models by restricting self-renewal of cancer stem cells and suppressing immune evasion.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 79-96.e11 |
| Journal | Cancer Cell |
| Volume | 38 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 13 2020 |
Keywords
- FTO
- LILRB4
- LSC/LIC self-renewal
- N-methyladenosine (mA) modification
- immune checkpoint genes
- immune evasion
- inhibitors
- leukemia
- solid tumors
- therapeutics
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS